fda glp-1 compounding warning letters september 2025 cracks down on 'misleading' compounded GLP-1s by telehealth companies - Indianapolis News | Indiana Weather | Indiana Traffic FDA Warns 30 Telehealth Companies

This is only available to patients of Lemon Water Wellness who are currently under the care of one of our naturopathic doctors

It is licensed by the MHRA solely for epilepsy and migraine prevention, and no NICE guidance supports its use for weight management

Abrupt discontinuation of GLP-1 drugs can trigger rebound appetite and rapid weight regain, while stopping Lipo C has minimal withdrawal risk because it is a supplement, not a drug

50 Bunner, A

Factors Influencing Duration in the Body Dosage: Higher doses may remain in circulation slightly longer, though the difference can be marginal

This is why researchers have been so interested in combining the two approaches, and why cagrilintide on its own produces appetite suppression through mechanisms that don't fully overlap with semaglutide or tirzepatide